Barriers to Immunotherapy in Ovarian Cancer: Metabolic, Genomic, and Immune Perturbations in the Tumour Microenvironment

SIMPLE SUMMARY: Immunotherapy hinges on stimulating patients’ immune system to fight cancer. This treatment has led to improved survival in patients with malignancies such as melanoma and lung cancer but, disappointingly, its benefits have not been as forthcoming in ovarian cancer. This review summa...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Racheal Louise, Cummings, Michele, Thangavelu, Amudha, Theophilou, Georgios, de Jong, Diederick, Orsi, Nicolas Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699358/
https://www.ncbi.nlm.nih.gov/pubmed/34944851
http://dx.doi.org/10.3390/cancers13246231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699358/
https://www.ncbi.nlm.nih.gov/pubmed/34944851
http://dx.doi.org/10.3390/cancers13246231

Ejemplares similares